CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
Mostert B, Kraan J, Sieuwerts AM, van der Spoel P, Bolt-de Vries J, Prager-van der Smissen WJ, Smid M, Timmermans AM, Martens JW, Gratama JW, Foekens JA, Sleijfer S.
Mostert B, et al. Among authors: sieuwerts am.
Cancer Lett. 2012 Jun 1;319(1):49-55. doi: 10.1016/j.canlet.2011.12.031. Epub 2011 Dec 24.
Cancer Lett. 2012.
PMID: 22202642